Mathieu Firmann

Summary

Affiliation: Centre Hospitalier Universitaire Vaudois
Country: Switzerland

Publications

  1. pmc The CoLaus study: a population-based study to investigate the epidemiology and genetic determinants of cardiovascular risk factors and metabolic syndrome
    Mathieu Firmann
    Department of Medicine, Internal Medicine, CHUV, Lausanne, Switzerland
    BMC Cardiovasc Disord 8:6. 2008
  2. doi request reprint Predictive accuracy of original and recalibrated Framingham risk score in the Swiss population
    Pedro Marques-Vidal
    Centre for Cardiovascular and Metabolic Research, CardioMet, Switzerland
    Int J Cardiol 133:346-53. 2009
  3. doi request reprint Cardiovascular risk estimation and eligibility for statins in primary prevention comparing different strategies
    David Nanchen
    Department of Ambulatory Care and Community Medicine, University Hospital Centre, University of Lausanne, Switzerland
    Am J Cardiol 103:1089-95. 2009
  4. doi request reprint Prevalence, treatment and control of dyslipidaemia in Switzerland: still a long way to go
    Mathieu Firmann
    Department of Medicine, Centre for Cardiovascular and Metabolic Research Cardiomet, University Hospital, University of Lausanne, Lausanne, Switzerland
    Eur J Cardiovasc Prev Rehabil 17:682-7. 2010

Detail Information

Publications4

  1. pmc The CoLaus study: a population-based study to investigate the epidemiology and genetic determinants of cardiovascular risk factors and metabolic syndrome
    Mathieu Firmann
    Department of Medicine, Internal Medicine, CHUV, Lausanne, Switzerland
    BMC Cardiovasc Disord 8:6. 2008
    ..A secondary aim of the CoLaus study will be to determine new genetic determinants associated with CVRFs...
  2. doi request reprint Predictive accuracy of original and recalibrated Framingham risk score in the Swiss population
    Pedro Marques-Vidal
    Centre for Cardiovascular and Metabolic Research, CardioMet, Switzerland
    Int J Cardiol 133:346-53. 2009
    ..To compare the predictive accuracy of the original and recalibrated Framingham risk function on current morbidity from coronary heart disease (CHD) and mortality data from the Swiss population...
  3. doi request reprint Cardiovascular risk estimation and eligibility for statins in primary prevention comparing different strategies
    David Nanchen
    Department of Ambulatory Care and Community Medicine, University Hospital Centre, University of Lausanne, Switzerland
    Am J Cardiol 103:1089-95. 2009
    ..Following the International Atherosclerosis Society and the Adult Treatment Panel III recommendations might prevent more CHD deaths at the cost of higher numbers needed to treat compared with European Society of Cardiology guidelines...
  4. doi request reprint Prevalence, treatment and control of dyslipidaemia in Switzerland: still a long way to go
    Mathieu Firmann
    Department of Medicine, Centre for Cardiovascular and Metabolic Research Cardiomet, University Hospital, University of Lausanne, Lausanne, Switzerland
    Eur J Cardiovasc Prev Rehabil 17:682-7. 2010
    ..There is little information regarding the prevalence and management of dyslipidaemia in Switzerland...